Publications by authors named "Richard Buick"

Claim this Profile
A
Antibody therapy in pancreatic cancer: mAb-ye we're onto something?
Anna J Boland, Anthony A O'Kane, Richard Buick, Daniel B Longley, Christopher J Scott

Biochim Biophys Acta Rev Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells.
Fatma Aboulnasr, Ashton Krogman, Rondell P Graham, Nathan W Cummins, Anisha Misra, Richard Buick

Clin Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors.
Ramiro Vázquez, Lucile Astorgues-Xerri, Mohamed Bekradda, Julie Gormley, Richard Buick

Biochimie· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity.
Hang Fai Kwok, Richard J Buick, Diana Kuehn, Julie A Gormley, Declan Doherty

Mol Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable expression and purification of a functional processed Fab' fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptor.
Nicolas Camper, Teresa Byrne, Roberta E Burden, Jenny Lowry, Breena Gray, Richard J Buick

J Immunol Methods· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and purification of diagnostically sensitive mycobacterial (Mycobacterium bovis) antigens and profiling of their humoral immune response in a rabbit model.
Hang Fai Kwok, Christopher J Scott, Philip Snoddy, Richard J Buick, James A Johnston

Res Vet Sci· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetizable antibody-like proteins.
Prabhjyot Kaur Dehal, Christine Frances Livingston, Claire Geekie Dunn, Richard Buick, Richard Luxton

Biotechnol J· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of recombinant proteins in Escherichia coli using an N-terminal tag derived from sortase.
Jill Caswell, Philip Snoddy, Darragh McMeel, Richard J Buick, Christopher J Scott

Protein Expr Purif· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells.
Ada Funaro, Giorgio Gribaudo, Anna Luganini, Erika Ortolan, Nicola Lo Buono, Richard Buick

BMC Biotechnol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment.
Roberta E Burden, Philip Snoddy, Richard J Buick, James A Johnston, Brian Walker

Mol Cancer Ther· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticles.
Christopher J Scott, Waleed M Marouf, Derek J Quinn, Richard J Buick, Selinda J Orr

Pharm Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.
Joanne Elliott, Oonagh T Lynch, Yvonne Suessmuth, Ping Qian, Caroline R Boyd, Richard Buick

J Virol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses.
Selinda J Orr, Nuala M Morgan, Richard J Buick, Caroline R Boyd, Joanne Elliott

J Biol Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody conjugates and therapeutic strategies.
Paul A McCarron, Shane A Olwill, Waleed M Y Marouf, Richard J Buick, Brian Walker

Mol Interv· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis